phosphatidylcholines has been researched along with galantamine in 2 studies
| Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (galantamine) | Trials (galantamine) | Recent Studies (post-2010) (galantamine) |
|---|---|---|---|---|---|
| 32,204 | 443 | 5,593 | 1,874 | 209 | 703 |
| Protein | Taxonomy | phosphatidylcholines (IC50) | galantamine (IC50) |
|---|---|---|---|
| Chain A, ACETYLCHOLINESTERASE | Tetronarce californica (Pacific electric ray) | 0.652 | |
| Chain A, Acetylcholinesterase | Tetronarce californica (Pacific electric ray) | 0.36 | |
| Acetylcholinesterase | Electrophorus electricus (electric eel) | 2.0401 | |
| Acetylcholinesterase | Tetronarce californica (Pacific electric ray) | 0.488 | |
| Cholinesterase | Homo sapiens (human) | 5.4792 | |
| Vascular endothelial growth factor receptor 1 | Homo sapiens (human) | 0.59 | |
| Acetylcholinesterase | Mus musculus (house mouse) | 2.29 | |
| Acetylcholinesterase | Homo sapiens (human) | 1.8484 | |
| Acetylcholinesterase | Bos taurus (cattle) | 4.53 | |
| Delta-type opioid receptor | Mus musculus (house mouse) | 8.3973 | |
| Vascular endothelial growth factor receptor 3 | Homo sapiens (human) | 0.59 | |
| Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | 0.59 | |
| Acetylcholinesterase | Rattus norvegicus (Norway rat) | 0.8006 | |
| Kappa-type opioid receptor | Cavia porcellus (domestic guinea pig) | 3.2 | |
| Cholinesterase | Equus caballus (horse) | 7.2215 | |
| Carboxylic ester hydrolase | Equus caballus (horse) | 8.4178 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Butler, R; Prabhakaran, P; Warner, J | 1 |
| Brandt, GC; Costantino, HR; Foerder, CA; Leonard, AK; Quay, SC; Sileno, AP | 1 |
1 review(s) available for phosphatidylcholines and galantamine
| Article | Year |
|---|---|
Dementia.
Topics: Alzheimer Disease; Anticonvulsants; Antipsychotic Agents; Carbamates; Donepezil; Galantamine; Ginkgo biloba; Humans; Indans; Nootropic Agents; Phenylcarbamates; Phosphatidylcholines; Physostigmine; Phytotherapy; Piperidines; Rivastigmine; Tacrine; Vitamin E | 2003 |
1 other study(ies) available for phosphatidylcholines and galantamine
| Article | Year |
|---|---|
In vitro formulation optimization of intranasal galantamine leading to enhanced bioavailability and reduced emetic response in vivo.
Topics: Administration, Intranasal; Administration, Oral; Analysis of Variance; Animals; beta-Cyclodextrins; Biological Availability; Cell Membrane Permeability; Cells, Cultured; Chemistry, Pharmaceutical; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Drug Compounding; Edetic Acid; Electric Impedance; Epithelial Cells; Excipients; Factor Analysis, Statistical; Ferrets; Galantamine; Humans; Phosphatidylcholines; Rats; Rats, Sprague-Dawley; Respiratory Mucosa; Tight Junctions; Vomiting | 2007 |